Skip to main content
Caplight Logo









Arkana Therapeutics

Arkana Therapeutics

Private
Boulder, ColoradoHealthcare & Life Scienceshttps://arkanatx.com/

Last Round

Pre Seed

Jun 29, 2026

Total Funding Raised

$1.03M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Arkana Therapeutics is a biotechnology company that discovers and develops metabolite-based therapeutics for obesity.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

targeted protein degradationlight-activated platformParkinson's diseaseprotein degraderneurodegenerative diseasephotopharmacologyalpha-synucleinsynucleinopathiesdrug discovery platformlight-inducible degraderdrug discoveryprecision medicinebiotechnology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Arkana Therapeutics Comparables

Compare Arkana Therapeutics with similar companies based on industry and business-model similarity.

Arkana Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Arvinas Inc
72%
Primary Peptides, Inc.
67%
Plexium
64%

Arkana Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedJun 29, 2026
GrantApr 22, 2026
GrantOct 27, 2025

Key People

Founding team and executive leadership

Jack Gugel

CEO & Co-Founder

Founding Team

Arkana Therapeutics Investors

Notable investors and investment history

Arkana Therapeutics investors
InvestorRounds
Venture Partners at CU BoulderGrant
Buff Gold VenturesGrant
OEDIT Advanced Industries ProgramGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 29, 2026

    $750K round completed

Arkana Therapeutics Filings

Explore SEC and related filing metadata, where available.

Arkana Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Arkana Therapeutics's valuation, stock price, and market status.

Is Arkana Therapeutics a public or private company?

Arkana Therapeutics is a private company.

What is the current stock price of Arkana Therapeutics?

Arkana Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Arkana Therapeutics worth (valuation)?

Valuation information for Arkana Therapeutics is not publicly available.

Can I buy Arkana Therapeutics stock?

Arkana Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Arkana Therapeutics's last funding round?

Funding round information for Arkana Therapeutics is not publicly available.

Who are the main investors in Arkana Therapeutics?

Investor information for Arkana Therapeutics is not publicly disclosed.

Will Arkana Therapeutics IPO soon?

No public IPO plans have been announced for Arkana Therapeutics.

How can I track Arkana Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Arkana Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBoulder, Colorado
Employee Range4
Year Founded2025
Last FundingJun 29, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?